Citius Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Citius Pharmaceuticals, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q4 2022 to Q2 2024.
  • Citius Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.17M.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.17M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $3.08M +$1.91M +164% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.06M +$1.86M +155% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q1 2023 $1.17M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.2M Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.